Phoebe Hildreth Yager, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intensive Care Units, Pediatric | 17 | 2024 | 1009 | 3.450 |
Why?
|
Telemedicine | 8 | 2020 | 2951 | 0.980 |
Why?
|
Teaching Rounds | 2 | 2020 | 275 | 0.930 |
Why?
|
Quality Improvement | 4 | 2024 | 3798 | 0.900 |
Why?
|
Critical Care | 7 | 2023 | 2677 | 0.870 |
Why?
|
Intubation, Intratracheal | 4 | 2024 | 1319 | 0.760 |
Why?
|
Hyperkalemia | 2 | 2021 | 229 | 0.730 |
Why?
|
Saline Solution, Hypertonic | 1 | 2020 | 112 | 0.670 |
Why?
|
Professional-Family Relations | 2 | 2020 | 488 | 0.640 |
Why?
|
Naloxone | 1 | 2021 | 363 | 0.630 |
Why?
|
Respiration, Artificial | 4 | 2024 | 2597 | 0.620 |
Why?
|
Hyponatremia | 1 | 2021 | 280 | 0.610 |
Why?
|
Hospitals, Pediatric | 4 | 2023 | 1830 | 0.600 |
Why?
|
Intracranial Pressure | 1 | 2020 | 321 | 0.590 |
Why?
|
Intracranial Hypertension | 1 | 2020 | 188 | 0.590 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 381 | 0.570 |
Why?
|
Emergency Medicine | 3 | 2017 | 1192 | 0.560 |
Why?
|
Hospital Rapid Response Team | 1 | 2016 | 55 | 0.510 |
Why?
|
Documentation | 1 | 2021 | 884 | 0.490 |
Why?
|
Videoconferencing | 1 | 2017 | 197 | 0.490 |
Why?
|
Sodium | 1 | 2020 | 1592 | 0.480 |
Why?
|
Heparin | 1 | 2022 | 1645 | 0.470 |
Why?
|
Manikins | 2 | 2017 | 237 | 0.470 |
Why?
|
Patient Care Team | 6 | 2020 | 2483 | 0.470 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2014 | 57 | 0.460 |
Why?
|
Babesia microti | 1 | 2014 | 31 | 0.460 |
Why?
|
Babesiosis | 1 | 2014 | 92 | 0.430 |
Why?
|
Child | 32 | 2024 | 79004 | 0.420 |
Why?
|
Tachycardia, Ventricular | 1 | 2021 | 1292 | 0.410 |
Why?
|
Pediatrics | 5 | 2020 | 3573 | 0.400 |
Why?
|
After-Hours Care | 1 | 2012 | 100 | 0.390 |
Why?
|
Blood | 1 | 2014 | 584 | 0.390 |
Why?
|
Intensive Care Units | 3 | 2023 | 3697 | 0.380 |
Why?
|
Neurologic Examination | 1 | 2014 | 910 | 0.380 |
Why?
|
Foramen Ovale, Patent | 1 | 2012 | 214 | 0.340 |
Why?
|
Shock | 2 | 2021 | 317 | 0.340 |
Why?
|
Attitude of Health Personnel | 2 | 2021 | 3821 | 0.330 |
Why?
|
Infant | 16 | 2024 | 35675 | 0.320 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2515 | 0.310 |
Why?
|
Physical Examination | 1 | 2014 | 1237 | 0.310 |
Why?
|
Systemic Inflammatory Response Syndrome | 3 | 2022 | 616 | 0.300 |
Why?
|
Mannose-Binding Lectin | 1 | 2008 | 146 | 0.280 |
Why?
|
Child, Preschool | 14 | 2024 | 41660 | 0.260 |
Why?
|
Thromboembolism | 1 | 2012 | 997 | 0.260 |
Why?
|
Airway Management | 3 | 2021 | 309 | 0.260 |
Why?
|
Curriculum | 4 | 2024 | 3654 | 0.260 |
Why?
|
Anemia | 1 | 2014 | 1495 | 0.240 |
Why?
|
Electronic Health Records | 1 | 2021 | 4632 | 0.230 |
Why?
|
Parents | 2 | 2019 | 3502 | 0.230 |
Why?
|
Multilingualism | 1 | 2024 | 87 | 0.220 |
Why?
|
Boston | 5 | 2020 | 9240 | 0.210 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2221 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3068 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3187 | 0.200 |
Why?
|
Child Mortality | 1 | 2024 | 201 | 0.200 |
Why?
|
Reperfusion Injury | 1 | 2008 | 1004 | 0.190 |
Why?
|
Cities | 1 | 2023 | 528 | 0.190 |
Why?
|
Physicians | 1 | 2019 | 4551 | 0.180 |
Why?
|
Humans | 45 | 2024 | 752411 | 0.180 |
Why?
|
Waste Management | 1 | 2020 | 19 | 0.180 |
Why?
|
Otolaryngology | 2 | 2020 | 676 | 0.180 |
Why?
|
Respiratory System | 2 | 2020 | 553 | 0.180 |
Why?
|
Organizational Policy | 2 | 2020 | 426 | 0.170 |
Why?
|
Adolescent | 14 | 2024 | 86766 | 0.170 |
Why?
|
Drug Dosage Calculations | 1 | 2020 | 116 | 0.170 |
Why?
|
Developing Countries | 3 | 2024 | 2819 | 0.170 |
Why?
|
Bioethical Issues | 1 | 2020 | 117 | 0.160 |
Why?
|
Brain Injuries | 2 | 2008 | 1967 | 0.160 |
Why?
|
Containment of Biohazards | 1 | 2019 | 37 | 0.160 |
Why?
|
Bioethics | 1 | 2020 | 115 | 0.160 |
Why?
|
Critical Illness | 4 | 2022 | 2685 | 0.160 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 169 | 0.150 |
Why?
|
Dexmedetomidine | 2 | 2014 | 313 | 0.150 |
Why?
|
Male | 22 | 2024 | 354908 | 0.150 |
Why?
|
Inservice Training | 1 | 2019 | 376 | 0.140 |
Why?
|
Outsourced Services | 1 | 2016 | 20 | 0.140 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2021 | 657 | 0.140 |
Why?
|
Narcotic Antagonists | 1 | 2021 | 568 | 0.140 |
Why?
|
Hospital Administration | 1 | 2020 | 353 | 0.140 |
Why?
|
Angiography | 1 | 2022 | 1607 | 0.140 |
Why?
|
Female | 20 | 2024 | 386085 | 0.130 |
Why?
|
Rabies Vaccines | 1 | 2015 | 28 | 0.130 |
Why?
|
Rabies virus | 1 | 2015 | 36 | 0.130 |
Why?
|
Transportation of Patients | 1 | 2016 | 174 | 0.130 |
Why?
|
Respiratory Therapy | 1 | 2015 | 127 | 0.120 |
Why?
|
Rabies | 1 | 2015 | 54 | 0.120 |
Why?
|
Emergency Treatment | 1 | 2019 | 497 | 0.120 |
Why?
|
Hypnotics and Sedatives | 2 | 2014 | 1150 | 0.120 |
Why?
|
Postoperative Care | 2 | 2011 | 1465 | 0.120 |
Why?
|
Medical Records | 1 | 2020 | 1403 | 0.120 |
Why?
|
Environment | 1 | 2020 | 1114 | 0.120 |
Why?
|
Tick-Borne Diseases | 1 | 2014 | 36 | 0.110 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2019 | 415 | 0.110 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1486 | 0.110 |
Why?
|
Dysarthria | 1 | 2012 | 58 | 0.100 |
Why?
|
Hypokalemia | 1 | 2013 | 152 | 0.100 |
Why?
|
Retrospective Studies | 10 | 2022 | 79133 | 0.100 |
Why?
|
Patient Transfer | 2 | 2016 | 771 | 0.100 |
Why?
|
Basilar Artery | 1 | 2012 | 203 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2021 | 2146 | 0.100 |
Why?
|
Efficiency, Organizational | 1 | 2016 | 689 | 0.100 |
Why?
|
Infection Control | 1 | 2019 | 971 | 0.100 |
Why?
|
Delivery of Health Care | 3 | 2024 | 5279 | 0.090 |
Why?
|
Brain Death | 2 | 2012 | 334 | 0.090 |
Why?
|
Communication | 2 | 2017 | 3806 | 0.090 |
Why?
|
Vomiting | 1 | 2014 | 634 | 0.090 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 1432 | 0.090 |
Why?
|
Hypovolemia | 1 | 2010 | 48 | 0.090 |
Why?
|
Homocystinuria | 1 | 2010 | 63 | 0.090 |
Why?
|
Ataxia | 1 | 2012 | 305 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2122 | 0.090 |
Why?
|
Stroke | 1 | 2012 | 9879 | 0.090 |
Why?
|
Quality Control | 1 | 2012 | 825 | 0.090 |
Why?
|
Disease Outbreaks | 1 | 2019 | 1739 | 0.080 |
Why?
|
Coma | 1 | 2012 | 427 | 0.080 |
Why?
|
Body Weight | 1 | 2020 | 4605 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2562 | 0.080 |
Why?
|
Pilot Projects | 3 | 2017 | 8443 | 0.080 |
Why?
|
Liver Failure, Acute | 1 | 2010 | 174 | 0.080 |
Why?
|
Patient Simulation | 1 | 2011 | 297 | 0.080 |
Why?
|
Adult | 7 | 2023 | 216927 | 0.080 |
Why?
|
Hospitalists | 1 | 2012 | 298 | 0.080 |
Why?
|
Observer Variation | 1 | 2014 | 2583 | 0.080 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2016 | 996 | 0.080 |
Why?
|
Death | 1 | 2012 | 652 | 0.080 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14325 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12901 | 0.080 |
Why?
|
Problem-Based Learning | 1 | 2011 | 354 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2427 | 0.070 |
Why?
|
Leukoencephalopathies | 1 | 2010 | 248 | 0.070 |
Why?
|
Complement C4 | 1 | 2007 | 244 | 0.070 |
Why?
|
Brain Edema | 2 | 2008 | 595 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2017 | 5148 | 0.070 |
Why?
|
Fluid Therapy | 1 | 2010 | 590 | 0.070 |
Why?
|
Fever | 1 | 2014 | 1611 | 0.070 |
Why?
|
Larynx | 1 | 2010 | 491 | 0.070 |
Why?
|
Complement Activation | 1 | 2008 | 444 | 0.070 |
Why?
|
Complement C3 | 1 | 2008 | 449 | 0.070 |
Why?
|
Respiratory Tract Diseases | 1 | 2011 | 745 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2024 | 39077 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 933 | 0.060 |
Why?
|
Vision Disorders | 1 | 2012 | 1072 | 0.060 |
Why?
|
Skin Diseases | 1 | 2014 | 1083 | 0.060 |
Why?
|
Prospective Studies | 5 | 2017 | 53809 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15680 | 0.060 |
Why?
|
Shock, Cardiogenic | 1 | 2010 | 715 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3427 | 0.060 |
Why?
|
Checklist | 1 | 2011 | 814 | 0.060 |
Why?
|
Tissue and Organ Procurement | 1 | 2012 | 898 | 0.060 |
Why?
|
Encephalitis | 1 | 2008 | 430 | 0.060 |
Why?
|
Antibodies, Viral | 1 | 2015 | 3106 | 0.060 |
Why?
|
Shock, Septic | 1 | 2010 | 759 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8511 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 1183 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2015 | 2236 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2020 | 25919 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2010 | 1527 | 0.050 |
Why?
|
Heart Rate | 1 | 2014 | 4092 | 0.050 |
Why?
|
Cell Death | 1 | 2008 | 1664 | 0.050 |
Why?
|
Biosensing Techniques | 1 | 1988 | 670 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2715 | 0.050 |
Why?
|
Acute Disease | 1 | 2012 | 7212 | 0.050 |
Why?
|
Heart Transplantation | 1 | 2015 | 3061 | 0.050 |
Why?
|
Radiography | 1 | 2012 | 6965 | 0.050 |
Why?
|
Recycling | 1 | 2020 | 15 | 0.050 |
Why?
|
Medical Waste | 1 | 2020 | 15 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7735 | 0.050 |
Why?
|
Disease Management | 1 | 2011 | 2480 | 0.050 |
Why?
|
Communication Barriers | 1 | 2024 | 412 | 0.050 |
Why?
|
Blood Pressure | 2 | 2014 | 8465 | 0.050 |
Why?
|
Equipment Reuse | 1 | 2020 | 43 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4117 | 0.040 |
Why?
|
Movement | 1 | 2007 | 1469 | 0.040 |
Why?
|
El Salvador | 1 | 2019 | 34 | 0.040 |
Why?
|
Sepsis | 1 | 2014 | 2588 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19901 | 0.040 |
Why?
|
Anesthesia | 1 | 2010 | 1550 | 0.040 |
Why?
|
Young Adult | 4 | 2021 | 57632 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14588 | 0.040 |
Why?
|
Africa, Western | 1 | 2019 | 155 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2012 | 3127 | 0.040 |
Why?
|
United States | 5 | 2021 | 71438 | 0.040 |
Why?
|
Patient Isolation | 1 | 2019 | 100 | 0.040 |
Why?
|
Equipment and Supplies | 1 | 2020 | 275 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6166 | 0.040 |
Why?
|
Recovery of Function | 1 | 2008 | 2921 | 0.040 |
Why?
|
Immunomodulation | 1 | 2021 | 543 | 0.040 |
Why?
|
Regional Medical Programs | 1 | 2016 | 68 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2004 | 2112 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2008 | 14297 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2884 | 0.030 |
Why?
|
Ecuador | 1 | 2014 | 58 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 73425 | 0.030 |
Why?
|
Video Recording | 1 | 2019 | 943 | 0.030 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2015 | 101 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1871 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 2015 | 285 | 0.030 |
Why?
|
Health Plan Implementation | 1 | 2016 | 332 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7400 | 0.030 |
Why?
|
Educational Measurement | 1 | 2019 | 1244 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3396 | 0.020 |
Why?
|
Positive-Pressure Respiration | 1 | 2015 | 631 | 0.020 |
Why?
|
Tissue Donors | 2 | 2015 | 2228 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6479 | 0.020 |
Why?
|
Immunity, Humoral | 1 | 2015 | 594 | 0.020 |
Why?
|
Clinical Competence | 2 | 2019 | 4715 | 0.020 |
Why?
|
Personnel, Hospital | 1 | 2012 | 284 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2842 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2441 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 13897 | 0.020 |
Why?
|
Alamethicin | 1 | 1988 | 2 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8539 | 0.020 |
Why?
|
Respiration | 1 | 2015 | 1646 | 0.020 |
Why?
|
Massachusetts | 2 | 2012 | 8710 | 0.020 |
Why?
|
Patient Admission | 1 | 2016 | 1376 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2015 | 824 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2008 | 17958 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40980 | 0.020 |
Why?
|
Electric Conductivity | 1 | 1988 | 402 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3573 | 0.020 |
Why?
|
Postoperative Period | 1 | 2011 | 1806 | 0.020 |
Why?
|
Lipid Bilayers | 1 | 1988 | 380 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13277 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 64250 | 0.020 |
Why?
|
Electrodes | 1 | 1988 | 609 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10475 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4876 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17647 | 0.020 |
Why?
|
Congenital Abnormalities | 1 | 2010 | 703 | 0.020 |
Why?
|
Safety Management | 1 | 2011 | 760 | 0.020 |
Why?
|
Surface Properties | 1 | 1988 | 1154 | 0.020 |
Why?
|
Program Evaluation | 1 | 2014 | 2464 | 0.020 |
Why?
|
Maze Learning | 1 | 2007 | 477 | 0.020 |
Why?
|
Calcium Channels | 1 | 1988 | 617 | 0.020 |
Why?
|
Registries | 1 | 2020 | 8367 | 0.010 |
Why?
|
Health Personnel | 1 | 2017 | 3266 | 0.010 |
Why?
|
Mice | 2 | 2008 | 80550 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3562 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21157 | 0.010 |
Why?
|
Cattle | 1 | 1988 | 3848 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10796 | 0.010 |
Why?
|
Animals | 3 | 2008 | 166811 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2004 | 1147 | 0.010 |
Why?
|
Ligands | 1 | 1988 | 3274 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10629 | 0.010 |
Why?
|
Equipment Design | 1 | 1988 | 3511 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2004 | 1828 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4571 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6372 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1988 | 2818 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2007 | 1865 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 217039 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2007 | 11008 | 0.010 |
Why?
|
Inflammation | 1 | 2007 | 10696 | 0.000 |
Why?
|